RECRUITING

Alzheimer Prevention Trials (APT) Webstudy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of the Alzheimer Prevention Trials (APT) Webstudy is to accelerate enrollment for Alzheimer's disease (AD) clinical trials by identifying and tracking individuals who may be at higher risk for developing AD dementia.

Official Title

Alzheimer Prevention Trials (APT) Webstudy

Quick Facts

Study Start:2017-12-20
Study Completion:2026-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03638583

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * male or female at least 50 years of age
  2. * no evidence of dementia
  3. * willing to participate in remote longitudinal cognitive testing and possible referral for biomarker assessment based on risk
  1. * N/A. Anyone can register for the APT Webstudy, however, only individuals identified using the risk algorithm will be referred for in-person biomarker assessments.

Contacts and Locations

Study Contact

APT Webstudy Team
CONTACT
858-877-3135
info@aptwebstudy.org

Principal Investigator

Paul Aisen, MD
PRINCIPAL_INVESTIGATOR
USC ATRI
Reisa Sperling, MD
PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital
Jeffrey Cummings, MD
PRINCIPAL_INVESTIGATOR
The Cleveland Clinic

Study Locations (Sites)

Https://Www.Aptwebstudy.Org
San Diego, California, 92121
United States

Collaborators and Investigators

Sponsor: University of Southern California

  • Paul Aisen, MD, PRINCIPAL_INVESTIGATOR, USC ATRI
  • Reisa Sperling, MD, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital
  • Jeffrey Cummings, MD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-12-20
Study Completion Date2026-04-30

Study Record Updates

Study Start Date2017-12-20
Study Completion Date2026-04-30

Terms related to this study

Keywords Provided by Researchers

  • Alzheimer's
  • Prevention
  • Web-Based

Additional Relevant MeSH Terms

  • Alzheimer Disease
  • Dementia